<DOC>
	<DOCNO>NCT00922649</DOCNO>
	<brief_summary>16-week , open-label , multi-center pilot study . Insulin pump naïve subject type 2 diabetes achieve glycemic target ( screen A1C ≥ 7.0 % ) establish regimen either : 1 ) ≥ 2 OAs ( Cohort A ) , 2 ) basal insulin ± OAs ( Cohort B ) , 3 ) basal-bolus insulin ± OAs ( Cohort C ) initiate basal-bolus therapy insulin pump use rapid-acting insulin analog .</brief_summary>
	<brief_title>Pilot Study Assessing Insulin Pump Therapy Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>1 . Is 18 75 year age , inclusive ; 2 . Has clinical diagnosis type 2 diabetes mellitus ; 3 . Is antiglutamic acid decarboxylase ( GAD ) antibody negative ; 4 . Has A1C ≥ 7.0 % ≤ 10.5 % ; 5 . Has body mass index ( BMI ) ≥ 25 kg/m2 ≤ 40 kg/m2 ; 6 . Is treat either ≥ 2 oral antidiabetic agent ( OA ) basal insulin ± OA ( ) basalbolus insulin ± OA ( ) least 3 month ( Subjects may also treat exenatide [ Byetta ] pramlintide [ Symlin ] . 7 . If concomitant metformin , serum creatinine &lt; 1.5 mg/dL ( male ) &lt; 1.4 mg/dL ( female ) ; 8 . If female , negative urine pregnancy test 1 . Has experience recurrent severe hypoglycemia ( &gt; 2 episode ) require assistance past 6 month ; 2 . Has clinical cardiovascular disease ( CVD ) evidence prior myocardial infarction , stroke , arterial revascularization and/or angina ischemic change ECG rest , change grade exercise test , positive cardiac image test result ; 3 . Has abnormality screen ( Visit 1 ) 12lead ECG deem investigator clinically significant ; 4 . Is currently treat expect require undergo treatment systemic steroid oral , intravenous , intramuscular route potent inhale , intrapulmonary , intranasal , topical steroid know high rate systemic absorption ; 5 . Currently abuse drug alcohol history abuse investigator 's opinion would cause individual noncompliant ; 6 . Has significant medical condition , laboratory finding , medical history investigator 's opinion may affect successful completion study and/or personal wellbeing ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2009</verification_date>
</DOC>